Showing results (1861-1870 of 1,950) with videos related to
Sort By:
Pageof 195
Nature Nanotechnology|November 6, 2019
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic painPaulina D Ramírez-García, Jeffri S Retamal, Priyank Shenoy, et al.The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|May 5, 2015
Translational research will fail without surgical leadership: SCOTRRCC a successful surgeon-led Nationwide translational research infrastructure in renal cancerGrant D Stewart, Antony C P Riddick, Frances Rae, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2025
ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical TrialsHillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.Nature Communications|December 20, 2022
Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progressionMarco Sciacovelli, Aurelien Dugourd, Lorea Valcarcel Jimenez, et al.Aging|August 19, 2019
DNA methylation-based estimator of telomere lengthAke T Lu, Anne Seeboth, Pei-Chien Tsai, et al.Journal of Medicinal Chemistry|October 27, 2006
Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesZhonghua Pei, Xiaofeng Li, Thomas W von Geldern, et al.Bioscience|October 7, 2021
Blue Waters, Green Bottoms: Benthic Filamentous Algal Blooms Are an Emerging Threat to Clear Lakes WorldwideYvonne Vadeboncoeur, Marianne V Moore, Simon D Stewart, et al.Nature|July 23, 2025
Global hotspots of mycorrhizal fungal richness are poorly protectedMichael E Van Nuland, Colin Averill, Justin D Stewart, et al.Contemporary Clinical Trials Communications|November 18, 2024
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and reportAngela Meade, Elena Frangou, Babak Choodari-Oskooei, et al.European Urology Focus|July 1, 2026
A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS)Ailbhe Lawlor, Mieke Van Hemelrijck, Charlotte Moss, et al.Pageof 195